Category · FY2027
C56 Malignant neoplasm of ovary
- Header · not billable
C56 is not billable. The category heads 4 billable codes in FY2027: the 4 codes directly below it.
Index → code
Where it sits
- Chapter 2 Neoplasms (C00-D49)
- C51-C58 Malignant neoplasms of female genital organs (C51-C58)
- C56 Malignant neoplasm of ovary
- Billable codes
- 4
- Subdivisions
- 4
- CC / MCC codes
- 4 / 0
- HCC V28 codes
- 4
- New FY2027
- 0
- Index entries
- 74
Codes in C56
- C56.1Malignant neoplasm of right ovaryBillableCC22
- C56.2Malignant neoplasm of left ovaryBillableCC22
- C56.3Malignant neoplasm of bilateral ovariesBillableCC22
- C56.9Malignant neoplasm of unspecified ovaryBillableCC22
CC/MCC: as a secondary diagnosis, unless the principal diagnosis is on the code’s PDX exclusion list (MS-DRG v44 Appendix C; list on the code card).
Instructions
At C56
Use additional code
- code to identify any functional activity
Notes that also apply
Block C51-C58 instructions (Includes 1): printed on the block page.
Chapter 2 instructions (Notes 8): printed on the chapter 2 page.
Index entries
- Carcinoma (malignant)›granulosa cell → C56-
- Carcinoma (malignant)›theca cell → C56.-
- Dermoid (cyst)›with malignant transformation → C56-
- Thecoma›malignant → C56-
- Cancer›ovarian → C56.9-
- Adenofibroma›endometrioid›malignant → C56-
- Brenner›tumor (benign)›malignant → C56
- Cyst (colloid) (mucous) (simple) (retention)›dermoid›with malignant transformation → C56.-
- Cystadenofibroma›endometrioid›malignant → C56.-
- Teratoma (solid)›ovary›embryonal, immature or malignant → C56-
- Tumor›Brenner›malignant → C56-
- Tumor›dermoid›with malignant transformation → C56-
- Tumor›granulosa cell›malignant → C56-
- Tumor›granulosa cell-theca cell›malignant → C56-
- Tumor›papillary›mucinous of low malignant potential → C56-
- Adenocarcinoma›papillocystic›unspecified site → C56.9
- Adenocarcinoma›pseudomucinous›unspecified site → C56.9
- Carcinoma (malignant)›papillocystic›unspecified site → C56.9
- Carcinoma (malignant)›pseudomucinous›unspecified site → C56.9
- Cystadenocarcinoma›mucinous›unspecified site → C56.9
- Cystadenocarcinoma›papillary›unspecified site → C56.9
- Cystadenocarcinoma›pseudomucinous›unspecified site → C56.9
- Cystadenocarcinoma›serous›unspecified site → C56.9
- Dysgerminoma›unspecified site›female → C56.9
- Tumor›mucinous of low malignant potential›unspecified site → C56.9
- Tumor›serous of low malignant potential›unspecified site → C56.9
- Cystadenoma›mucinous›borderline malignancy›ovary → C56.-
- Cystadenoma›papillary›borderline malignancy›ovary → C56.-
- Cystadenoma›pseudomucinous›borderline malignancy›ovary → C56.-
- Cystadenoma›serous›borderline malignancy›ovary → C56.-
- Tumor›endodermal sinus›unspecified site›female → C56.-
- Adenocarcinoma›duct›unspecified site›female → C56.9
- Adenocarcinoma›papillary›serous›unspecified site → C56.9
- Adenocarcinoma›serous›papillary›unspecified site → C56.9
- Androblastoma›malignant›unspecified site›female → C56.9
- Arrhenoblastoma›malignant›unspecified site›female → C56.9
- Carcinoma (malignant)›endometrioid›unspecified site›female → C56.9
- Carcinoma (malignant)›Leydig cell (testis)›unspecified site›female → C56.9
- Carcinoma (malignant)›papillary›serous›unspecified site → C56.9
- Carcinoma (malignant)›serous›papillary›unspecified site → C56.9
34 more, longer entries are not listed; the search box finds them by word.
NCHS Alphabetic Index. Index first, then the Tabular List.